BioSpace News Archive

RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on commercialization and development of proprietary drugs for the treatment of gastrointestinal diseases, today announced that it has initiated promotion of Aemcolo® (rifamycin) in the U.S. for the treatment of travelers’ diarrhea caused by non-invasive strains of Escherichia Coli (E. coli) in adults

LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced it has entered into an exclusive license with Oregon Health & Science University (“OHSU”) to intellectual property rights owned by OHSU while also extending a sponsored research agreement

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced that it will host a key opinion leader (KOL) call on Epigenetics, Thursday, December 19th at 12pm Eastern Time.

ChromaCode, Inc., a molecular diagnostics company, announced it has secured $28 million in Series C financing.

New pricing structure will enable researchers to save close to 50% on 3D models for liver toxicology and drug safety testing applications.

NBC News’ Kate Snow to headline event at the University of Southern California’s Bovard Auditorium

MEI Pharma, Inc. announced that it has priced the underwritten public offering of 28,125,000 shares of its common stock at $1.60 per share for total gross proceeds, before underwriting commissions and estimated expenses, of approximately $45,000,000.

Nimbus Therapeutics announced the promotion of Chief Medical Officer, Annie C. Chen, M.D., MPH, to President of the company’s Tyk2 subsidiary, Nimbus Lakshmi, Inc.

Technavio has announced its latest market research report titled global autotransfusion devices market 2020-2024.

The addition to the NBI will become effective prior to market open on Monday, December 23, 2019.